An interventional study of Indoor Rock Climbing Exercise Training Program in Lifestyle Factors, Physical Inactivity and Quality of Life, sponsored by Northern Michigan University. Completed at 1 site in United States. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-13.
Sponsored by Northern Michigan University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 452 studies in Sedentary Behavior with a site in United States — 61 open to participants now, 89 under way, none of them phase 3. Sedentary Behavior · United States.
Among the 452 studies in Sedentary Behavior with a site in United States, this one is the 399th largest by enrollment of the 421 interventional ones that give a count, is one of 39 that started in 2024, is one of 386 with no phase, and was the 385th registered.
1,276 studies on the registry are indexed under Sedentary Behavior; 292 are open to participants now.
Browse Sedentary Behavior studies →61 of the 452 studies in Sedentary Behavior with a site in United States are open now. Recruiting first, the newest first:
St. Louis University · Sites in United States
Ages 18–69
University of Pittsburgh · Sites in United States
Ages 14–26
University of Wisconsin, River Falls · Sites in United States
Ages 18–60 · Healthy volunteers
The University of Tennessee, Knoxville · Sites in United States
Ages 65+
San Diego State University · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 184 Sedentary Behavior studies recruiting now, 77 (42%) set no upper age limit and 82 (45%) stop at 75 or younger; 30 take children under 18; 97 take healthy volunteers.
This study: 18 Years to 35 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
452 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 19 · Phase 2 15 · Phase 3 3 · Phase 4 2
First in 2000; this study’s year is marked. 39 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 6 is below the median of 60 across 1,077 interventional studies indexed under Sedentary Behavior.
Median enrollment 60 across the 421 interventional studies, 122 across the 30 observational. Of the 335 that completed or were terminated, 105 (31%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 452 have an industry lead sponsor. The 10 most frequent:
Northern Michigan University is the lead sponsor of 4 studies on the registry; 1 is open to participants now.
Northern Michigan University has 1 study filed under Sedentary Behavior — fewer than ten, so there is no comparison to draw.
40 of the studies in Sedentary Behavior with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07520786University of GeorgiaChanges in 24-hour Activity Cycle Behaviors During a Time-Restricted Eating Intervention in College-Aged Women | 2026-11 |
| NCT06923397Dana-Farber Cancer InstituteInterrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial | 2026-11-28 |
| NCT06116435University of Colorado, DenverA Pilot Factorial Trial of an Integrated Lifestyle Intervention | 2026-12 |
| NCT06754280University of Illinois at ChicagoAn Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease | 2026-12 |
| NCT07270016University of PittsburghPilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes | 2026-12 |
Add all 40 to your calendar (.ics) → With an account.
Among the 452 studies in Sedentary Behavior with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim of this pilot study is to determine the effects of a 12-week indoor rock climbing training program on heart health, mental health, and behavioral health in generally healthy adults aged 18-35 years old who do not exercise. Participants will learn to rock climb using ropes on an indoor rock climbing wall and participate in the training program 2-3 days per week for 60 minutes each session over 12 weeks. Health outcomes will be measured at 4 time points over the course of the study (pre-intervention, 6-weeks/mid-intervention, 12-weeks/post-intervention, and 24-weeks post-intervention).
The purpose of this study is to determine the effects of a 12-week progressive, supervised indoor rock climbing intervention on physical, mental, and behavioral health outcomes in physically inactive adults. This will be a pilot study used for informing a larger, randomized controlled trial. Measurements include: cardiometabolic disease risk factors (e.g., blood pressure, fasting glucose and lipids, hemoglobin a1c), health-related components of physical fitness (e.g., cardiorespiratory fitness, muscular fitness, dynamic balance, body composition), health-related quality of life, and behavior change variables (e.g., attitudes toward physical activity, self-efficacy for exercise, objective physical activity and sedentary behavior). The majority of rock climbing-related studies focus on enhancing performance in high-level climbing athletes and very little research has examined the specific impact of climbing physical activity on cardiovascular health parameters. Indoor climbing has demonstrated to be an activity that is safe for many individuals and does not require a high level initial fitness to partake in the activity. This study will engage generally healthy, physically inactive adults (aged 18-35 y) in an indoor rock climbing program 2 times per week for 60 minutes for the first 4 weeks and progressing to 3 times per week for 60 minutes for the last 8 weeks. Participants will partake in top-rope style rock climbing and bouldering. Data collection will occur over three visits to the School of Health and Human Performance Research Lab at four time points throughout the course of the study (baseline/pre-intervention, 6-weeks/mid-intervention, 12-weeks/post-intervention, 24-weeks post-intervention; total of 12 data collection visits).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in the control arm will be asked to maintain their current lifestyle behaviors.
Participants in the intervention arm will be asked to partake in a 12-week progressive, supervised, indoor rock climbing training program.
Behavioral: Indoor Rock Climbing Exercise Training Program
Training will occur 2-3 days per week for 60 minutes; ratings of perceived exertion between 3-7 on a scale of 0-10 will be targeted for the desired intensity throughout the program. Minutes of rock climbing will also be monitored to develop the progression strategy.
Fasting lipids
HDL-c; LDL-c; total cholesterol, triglycerides measured via capillary blood sample and point-of-care testing
Time frame: 0, 6, 12, 24 weeks
Fasting glucose
glucose (mg/dL) measured via capillary blood sample and point-of-care testing
Time frame: 0, 6, 12, 24 weeks
Hemoglobin a1c
Glycosylated hemoglobin (%) measured via capillary blood sample and point-of-care testing
Time frame: 0, 6, 12, 24 weeks
Physical activity and sedentary behavior
Objectively monitored light, moderate, and vigorous physical activity minutes per week
Time frame: 0, 6, 12, 24 weeks
Sedentary behavior bouts (30 min, 60 min, >60 min)
Objectively monitored number of bouts of sedentary behavior occurring in bouts of 30 minutes or less, 30-60 minutes, and greater than 60 minutes
Time frame: 0, 6, 12, 24 weeks
Cardiorespiratory fitness
VO2max (mL/kg/min) measured via expired air analysis
Time frame: 0, 12 weeks
Muscular fitness
Maximal isometric handgrip strength (kg) using an electronic handgrip dynamometer
Time frame: 0, 12 weeks
Handgrip strength asymmetry
Maximal isometric handgrip strength measured using an electronic handgrip dynamometer on both hands
Time frame: 0, 12 weeks
Lower-body dynamic balance
Lower-quarter y-balance test distance (cm) on each leg, in the anterior, posteromedial, and posterolateral directions.
Time frame: 0, 12 weeks
Health-related quality of life using CDC Health-Related Quality of Life Scale
Core healthy days module, activity limitations module. Core healthy days module measures the number of days over the past 30 days where injury, mental health, was not good and kept individuals from performing usual activities. Activity limitations asks if individuals are limited by any health problems, how many days they are limited by health problems, and if needs are impaired. Healthy days symptom module asks if pain, depression, anxiety and sleep were an issue on any number of days over the past 30 days. Additionally, how many days individuals felt healthy and full of energy over the past 30 days.
Time frame: 0, 6, 12, 24 weeks
Exercise self-efficacy measured via Self-efficacy for exercise scale
Self-efficacy for exercise scale is 9 items representing various scenarios that are measured on a scale of 1 (not confident) to 10 (very confident) a participant feels to exercise in that scenario. Higher scores represent higher self-efficacy for exercise participation.
Time frame: 0, 6, 12, 24 weeks
Perceptions of exercise measured via Views and Attitudes Toward Exercise Scale
Views and attitudes towards exercise scale is 15 items measured on a 7-point Likert scale from strongly disagree (lowest) to strongly agree (highest). Sum up all responses, higher scores are better perceptions of exercise.
Time frame: 0, 6, 12, 24 weeks
Perceived stress
Perceived stress scale items are scored from adding up each alternative over 10 items: 0=never, 1=almost never, 2=sometimes, 3=fairly often, 4=very often. 0-13=low stress, 14-26=moderate stress, 27-40=high perceived stress.
Time frame: 0, 6, 12, 24 weeks
Blood pressure
Systolic and diastolic blood pressure (mmHg) measured via automated blood pressure cuff.
Time frame: 0, 6, 12, 24 weeks
Body composition
Fat free mass, fat mass in kg using Dual-energy x-ray absorptiometry
Time frame: 0, 12, 24 weeks
Bone density
Total bone density (g/cm3) using Dual-energy x-ray absorptiometry
Time frame: 0, 12, 24 weeks
Plan to share: No — This is a small pilot study; individual participant data will not be shared to protect participants information so that it remains confidential.
No publications or documents are linked to this record.
Ran from Apr 2024 to primary completion in Jun 2025, 14 months.
Of 736 non-industry interventional studies with no phase under Sedentary Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 30. This study's 14 months is close to that.
Counting every sponsor, half of 744 studies reached it within 14 months; a quarter within 6 and three quarters within 30.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 13, 2026: primary completion Dec 2024 → Jun 2025 and completion Dec 2024 → Dec 2025.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Northern Michigan University